micafungin

Micafungin (Mycamine) is approved for use in adults and children for the treatment of infections in the blood, stomach, and esophagus caused by a fungus called Candida. This medication can also be used for prevention of fungal infections in adults and children who have had a bone marrow transplant. Additionally, the Infectious Diseases Society of America (IDSA) recommends micafungin (Mycamine) for the treatment of Candida infections in certain other parts of the body too. The medication isn't FDA approved for this purpose, but professional organizations like the IDSA have recommended it based on strong clinical evidence. Micafungin (Mycamine) is mostly used as part of empiric therapy, which means it's used to fight possible fungal infections when it's not known which specific fungus is causing an infection. It might also be used for people who have infections that are difficult to treat with (resistant to) fluconazole (Diflucan) and other similar antifungals.

Micafungin (Mycamine) is an antifungal medication. It kills fungi by preventing their ability to make a protective covering around themselves.

Micafungin (Mycamine) is typically given as an injection through the veins (intravenously or IV) in the hospital. Each infusion takes about 1 hour.

The typical dose in adults for the treatment of fungal infections is 100 mg or 150 mg injected through your vein (intravenously or IV) once per day, depending on the site of infection. For the prevention of fungal infections, the typical dose is 50 mg IV once per day. The dose for children 4 months of age and older is based on their body weight.